|1.||Roomi, M W: 4 articles (01/2014 - 12/2009)|
|2.||Kalinovsky, T: 3 articles (01/2014 - 03/2010)|
|3.||Niedzwiecki, A: 3 articles (01/2014 - 03/2010)|
|4.||Rath, M: 3 articles (01/2014 - 03/2010)|
|5.||Hildesheim, Allan: 3 articles (08/2010 - 11/2002)|
|6.||Cuneo, Antonio: 2 articles (12/2015 - 03/2012)|
|7.||Saccenti, Elena: 2 articles (12/2015 - 03/2012)|
|8.||Bardi, Antonella: 2 articles (12/2015 - 03/2012)|
|9.||Negrini, Massimo: 2 articles (12/2015 - 03/2012)|
|10.||Cavazzini, Francesco: 2 articles (12/2015 - 03/2012)|
04/30/1998 - "Infection of pigs with many strains of African Swine Fever Virus (ASFV) has been shown to cause a loss or marked decrease in the ability of splenocytes to respond to mitogens. "
12/01/1983 - "There were significant suppression of peripheral blood leukocyte responses to T-cell mitogens early in the course of infection and delayed onset of virus-specific cell-mediated immunity. "
01/01/1984 - "Acute CMV infection in the mouse results in depressed antibody production, IFN induction, lymphocyte proliferation responses to mitogens, allogeneic skin graft rejection, and clearance of certain bacteria and fungi from the blood stream. "
01/01/2013 - "Many studies have used in vitro and in vivo models employing mitogens to induce the expression of the characteristic proinflammatory mediators triggered by infection. "
09/01/1995 - "In this study, we examined the mechanisms by which avian reovirus infection of chickens depresses in vitro proliferative responses of spleen cells to T cell mitogens. "
06/01/1990 - "There was a progressive improvement in delayed dermal hypersensitivity (DDH) and in lymphocyte proliferative responses to two mitogens; this may have been due to one or more components of the multivitamin/mineral supplement administered to all study subjects. "
01/01/2010 - "The ability of blood lymphocytes to respond to stimulation by mitogens decreases, as does the cutaneous delayed type hypersensitivity response. "
05/01/2007 - "The biological activites of the obtained compounds were analyzed in the humoral immune response and delayed type hypersensitivity reaction to sheep red blood cells (SRBC) in the mouse model, as well as in the proliferative response of splenocytes to T-cell and B-cell mitogens in vitro."
12/11/1998 - "The relationship between the magnitude of cutaneous hypersensitivity to mitogens and selection for antibody responsiveness is discussed."
12/11/1998 - "Cutaneous hypersensitivity either initiated by T-cell mitogens as well as B-cell mitogens may depend for an important part on the rapid induction of local homing of lymphocytes towards the sensitizing agent, which may be mediated by an acute local expression of molecules with chemo-attractive capacities. "
|3.||Breast Neoplasms (Breast Cancer)
01/01/2012 - "Biological determinants of breast density, a strong predictor of human breast cancer risk, are postulated to be influenced by prenatal exposures to mitogens. "
06/18/2008 - "THF-diols (9,12-oxy-10,13-dihydroxyoctadecanoic and 10,13-oxy-9,12-dihydroxyoctadecanoic acids) are endocrine disrupters in rats and mitogens in breast cancer cells. "
01/01/2007 - "Prenatal levels of mitogens may influence the lifetime breast cancer risk by driving stem cell proliferation and increasing the number of target cells, and thereby increasing the chance of mutation events that initiate oncogenesis. "
01/01/2003 - "Importantly, this bi-directional regulation is often in a positive manner and the resulting synergism noted between these two potent mitogens may be a critical element in the progression of breast cancer. "
10/07/2002 - "These data show an association between blood levels of breast mitogens and mammographic density, and suggest a biological basis for the associated risk of breast cancer."
|4.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/01/1982 - "Lymphocyte response to mitogens and to lymphocyte suppressor and monocyte helper activity was studied in 18 patients with acute myeloid leukemia in complete remission, and in 17 healthy controls. "
02/01/1982 - "The present study also revealed that lymphocytes in ANLL respond poorly to PHA in the presence of high numbers of blasts but do respond well to mitogens during remission. "
07/01/1989 - "Peripheral blood lymphocytes of both groups of patients showed a significant reduction in the proliferative response to both T and B-cell mitogens, the values for the mitogens ConA and PWM being significantly lower in aspergilloma patients than in those with non-mycotic sinusitis. "
01/01/1989 - "Additionally, peripheral blood lymphocytes in both groups of patients showed a significant reduction in the proliferative response to both T- and B-cell mitogens, with the values for the mitogens ConA and PHA being significantly lower in the aspergilloma patients as compared to those with non-mycotic sinusitis. "
04/01/1990 - "Two years later, the in vivo response to recall antigens was normal in both groups of patients, whereas the response to mitogens (ConA, PHA and PWM) was still decreased in the aspergillus sinusitis groups. "
|3.||Insulin-Like Growth Factor I (IGF-1)
|4.||Immunoglobulin A (IgA)
|5.||HLA-DR Antigens (HLA-DR)
|7.||Mycobacterium tuberculosis antigens
|10.||Muromonab-CD3 (Muromonab CD3)
|2.||Homologous Transplantation (Allograft)
|3.||Combination Drug Therapy (Combination Chemotherapy)
|4.||Drug Therapy (Chemotherapy)